What is the appropriate dose of Bromfed (brompheniramine) for a 2‑year‑old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bromfed Should NOT Be Used in a 2-Year-Old Child

Based on current FDA labeling and major guideline recommendations, OTC cough and cold medications containing brompheniramine (like Bromfed) should generally be avoided in children under 6 years of age due to lack of proven efficacy and significant safety concerns, including reported fatalities. 1

Critical Safety Concerns

The 2008 practice parameter from the Journal of Allergy and Clinical Immunology explicitly states that OTC cough and cold medications should generally be avoided in all children below 6 years of age due to:

  • Documented fatalities: Between 1969-2006, there were 9 deaths associated with brompheniramine in children ≤6 years, with 41 total antihistamine-related deaths in this age group 1
  • Common overdose scenarios: Multiple product use, medication errors, and accidental exposures 1
  • Lack of proven efficacy: Controlled trials show antihistamine-decongestant combinations are not effective for upper respiratory infections in young children 1

FDA Labeling Guidance

While the FDA label for Bromfed technically provides dosing for ages 2-6 years (2.5 mL or ½ teaspoonful every 4 hours) 2, this contradicts the stronger safety recommendation from the FDA's own advisory committees, which in 2007 recommended against OTC cough/cold medications for children under 6 years 1.

The label itself states for infants 6 months to under 2 years: "Dosage to be established by a physician" 2, indicating this age group requires medical supervision if used at all.

Safer Alternatives for a 2-Year-Old

If treating allergic rhinitis specifically (not upper respiratory infections):

  • Second-generation antihistamines like cetirizine, loratadine, or desloratadine are preferred, as they have been shown to be well-tolerated with excellent safety profiles in young children 1
  • The 2015 guideline provides specific dosing for these safer alternatives in 2-5 year olds 3

Clinical Decision Algorithm

  1. Determine the indication: Is this for allergic rhinitis or a common cold?
  2. If common cold/URI: Avoid Bromfed entirely—no proven benefit 1
  3. If allergic rhinitis: Use second-generation antihistamines instead (cetirizine 2.5 mg once or twice daily for ages 2-5) 3
  4. If Bromfed must be considered: Only under direct physician supervision with careful dosing and monitoring for sedation, which is more prevalent in the 2-5 year age group 4

Key Pitfall to Avoid

Do not assume that because an FDA label provides a dose, it represents current best practice. The voluntary market withdrawal of these products for children under 2 years in 2007 and subsequent FDA advisory committee recommendations reflect evolving safety standards that supersede older labeling 1.

References

Guideline

the diagnosis and management of rhinitis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2008

Guideline

clinical practice guideline: allergic rhinitis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.